THE DETERMINATION OF BIOMARKERS OF CEREBROSPINAL FLUID OF IDIOPATHIC NORMAL PRESSURE HYDRO- CEPHALUS AND ITS COMBINATION WITH ALZHEIMER'S DISEASE


Cite item

Full Text

Abstract

The idiopathic normal pressure hydrocephalus (Hakim-Adams syndrome) is characterized by the expansion of liquor-containing cavities, which is clinically manifested by a triad of symptoms: impaired gait, cognitive impairment, and impaired urination. One of the most common diseases associated with iNPH is Alzheimer's disease. Both diseases are found in the same age group with similar complaints of memory impairment. In clinical practice, their differential diagnosis is based on the identification of the Hakim-Adams triad. However, the determination of the combination of these two states, which is observed with a frequency of up to 75%, is a difficult task. In the study, the concentrations of biomarker proteins of amyloidosis and neurodegeneration in cerebrospinal fluid were determined. A total of 47 patients were examined (14 with a diagnosis of idiopathic normotensive hydrocephalus, 25 with Alzheimer's disease, 8 with their combination). The level of proteins in the cerebrospinal fluid was assessed using enzyme-linked immunosorbent assay (ELISA). Tablets for 96 samples were used to determine each of the evaluated indicators: the content of beta-amyloid (Aβ-42), tau protein (tau) and 218-phosphorylated tau protein (ftau). The neurodegeneration coefficients were calculated (ftau/Aβ-42, tau/Aβ-42). Specific cerebrospinal fluid changes in patients with idiopathic normotensive hydrocephalus were found to have higher levels of amyloid beta, a decrease in the content of tau and phosphorylated tau protein compared with patients with Alzheimer's disease. In the case of a combination of diseases (“comorbidity”), the presence of “intermediate” results by liquorological indicators is characteristic. A higher level of amyloid beta compared with Hakim-Adams syndrome indicates amyloidogenesis. We also revealed patterns of transformation of moderate cognitive impairment into dementia (according to the ratio of tau / Aβ-42 and ftau / Aβ-42).

About the authors

A. V Lapina

S.M. Kirov Military Medical Academy of the Ministry of Defense

St. Petersburg, Russia

References

  1. Гаврилов, Г.В. Патологические изменения в биоптатах головного мозга пациентов при идиопатической нормотензивной гидроцефа-лии / Г.В. Гаврилов, А.В. Станишевский, Б.В. Гайдар [и др.] // Журнал неврологии и психиатрии им. С.С. Корсакова. - 2019. - Т.119, №3. - С.50-54.
  2. Дамулин, И.В. Нормотензивная гидроцефалия: клиника, диагностика, лечение / И.В. Дамулин, Н.А. Орышич // Регулярные выпуски «РЖМ». - 2000. - №13. - C.589.
  3. Емелин, А.Ю. Болезнь Альцгеймера: Учебное пособие / А.Ю. Емелин, В.Ю. Лобзин, И.С. Железняк, И.В. Бойков. - СПб., 2016. - 76 с., ил.
  4. Иванова, М.Ф. Нормотензивная гидроцефалия Хакима-Адамса (научный обзор и личное наблюдение) / М.Ф. Иванова, С.К. Евту-шенко, А.В. Семенова, Е.А. Савченко // International neurological journal. - 2016. - Т.79, №1. - С.20-27.
  5. Chawla, J.C. Motor disorder in “normal pressure” hydrocephalus / J.C Chawla, J. Woodward // Brit. Med. J. - 1972. - Vol.1. - P.485-486.
  6. Halperin, J.J. Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology / J.J. Halperin, R. Kurlan, J.M. Schwalb [et al.] // Neurology. - 2015. - Vol.85, №23. - P.2063-2071.
  7. Masao, M. Impact of Cerebrospinal Fluid Shunting for Idiopathic Normal Pressure Hydrocephalus on the Amyloid Cascade / M. Masao, M. Masakazu, N. Madoka // PLoSOne. - 2015. - Vol.10, №3. - P.25-30.
  8. Zohn, R.C. Normal Pressure Hydrocephalus: How Can It Be Told Apart From Neurodegenerative Diseases of the Elderly? / R.С. Zohn // The Science Journal of the Lander College of Arts and Sciences. - 2012. - Vol.6, №1. - P.76-87.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Lapina A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).